EUVIMEDEUVIMED entdecken
Crossref

Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1

Siling Liu, Linjie Su, Jie Li, Yuexin Zhang, Xiaopei Hu, Pengcheng Wang, Peiqing Liu, Jiantao Ye

Molecular and Cellular Endocrinology · 2024

DOI: 10.1016/j.mce.2024.112252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Siling Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-Sen University, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangd…. Hauptthemen laut MEDLINE: MicroRNAs, Isoproterenol, Cardiomegaly, Myocytes, Cardiac. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological cardiac hypertrophy often precedes heart failure due to various stimuli, yet effective clinical interventions remain limited. Recently, microRNAs (miRNAs) have been identified as critical regulators of cardiovascular development. In this study, we investigated the role of miR-146b-5p and its underlying mechanisms of action in cardiac hypertrophy. Isoprenaline (ISO) treatment induced significant hypertrophy and markedly enhanced the expression of miR-146b-5p in cultured neonatal rat cardiomyocytes and hearts of C57BL/6 mice. Transfection with the miR-146b-5p mimic led to cardiomyocyte hypertrophy accompanied by autophagy inhibition. Conversely, miR-146b-5p inhibition significantly alleviated ISO-induced autophagy depression, thereby mitigating cardiac hypertrophy both in vitro and in vivo. Our results showed that the autophagy-related mediator double FYVE domain-containing protein 1 (DFCP1) is a target of miR-146b-5p. MiR-146b-5p blocked autophagic flux in cardiomyocytes by suppressing DFCP1, thus contributing to hypertrophy. These findings revealed that miR-146b-5p is a potential regulator of autophagy associated with the onset of cardiac hypertrophy, suggesting a possible therapeutic strategy involving the inhibition of miR-146b-5p.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsIsoproterenolCardiomegalyMyocytes, CardiacAutophagyMice, Inbred C57BLAnimalsRats, Sprague-DawleyRatsMaleMiceCells, CulturedGene Expression RegulationAutophagy-Related ProteinsBase Sequence

Stichwörter der Autor:innen

AutophagyCardiac hypertrophyDFCP1IsoprenalineMiR-146b-5p

Substanzen

MicroRNAsIsoproterenolMirn146 microRNA, mouseAutophagy-Related Proteins

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Sun Yat-Sen University, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, China.
  • School of Pharmaceutical Sciences, Sun Yat-Sen University, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, China…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, S., Su, L., Li, J., Zhang, Y., Hu, X., Wang, P., Liu, P., & Ye, J. (2024). Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112252

Vancouver

Liu S, Su L, Li J, Zhang Y, Hu X, Wang P, et al. Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112252

BibTeX
@article{Liu2024,
  author = {Liu, Siling and Su, Linjie and Li, Jie and Zhang, Yuexin and Hu, Xiaopei and Wang, Pengcheng and Liu, Peiqing and Ye, Jiantao},
  title = {Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1},
  journal = {Molecular and Cellular Endocrinology},
  year = {2024},
  doi = {10.1016/j.mce.2024.112252}
}
Kostenlos starten →